Sentiment · SYK
Lobbying Spend for SYK
AI-generated plain-English read of lobbying spend for SYK. Updated daily.
Moderate lobbying, rising
highModerate spend trending upward. Worth monitoring — a sustained rise from this base could reach the heavy tier within a year if the trajectory holds.
What will probably happen
- A rising trend without an obvious single catalyst suggests broadening DC engagement — a structural shift, not a one-quarter reaction.
- Spend is spread across many issue areas — the company has diverse regulatory exposure and is fighting on multiple fronts simultaneously.
What to do
- If you HOLD this stock
- This lobbying read is structural, not a timing signal. Hold as planned; revisit if trajectory changes next quarter.
- If you're EVALUATING this stock
- No sharp lobbying signal to factor into entry timing. Evaluate on fundamentals.
- If you trade OPTIONS
- No clean options signal derived from this lobbying read.
30 quarters of history with $7.96M in total spend — sufficient data for a reliable trajectory read.
Technical details
Technical analysis
- Spend tier
- Moderate
- Trajectory
- Rising
- Last quarter
- $485.0K
- Last 4Q total
- $1.94M
- Prior 4Q total
- $1.71M
- Top issue area
- HEALTH ISSUES (38% of spend)
- Top registrant
- STRYKER CORPORATION (62% of spend)
- Registrant base
- In house
- Quarters on record
- 30
- Unique issue areas
- 7
- Unique registrants
- 7
- Issue concentration
- Broad
Key levels
| Level | Value |
|---|---|
| total amount | 7,960,000 |
| last 4q total | 1,935,000 |
| top issue pct | 0.381 |
| prior 4q total | 1,710,000 |
| top registrant pct | 0.617 |
| last quarter amount | 485,000 |
Caveats
- Lobbying disclosures are quarterly and reflect activity already past. The signal is structural, not timing.
- The primary registrant appears to be an in-house government-affairs operation. In-house lobbying may not be captured in full by third-party disclosure data.